Loading...
Market
Primary reason for potential PREP Act amendment by end of 2025?
2
Resolution / Starting Odds
Public Health Concerns • 25%
Legal Challenges • 25%
Political Pressure • 25%
No Amendment • 25%
Official government announcements or legislative documents
Story
Biden Administration Extends PREP Act Liability Shield for COVID-19 Vaccines Until 2029, Despite End of Emergency
Dec 13, 2024, 04:42 PM
The Biden administration, through Health and Human Services Secretary Xavier Becerra, has extended the Public Readiness and Emergency Preparedness Act (PREP Act) declaration for COVID-19 countermeasures through December 31, 2029. This decision provides liability immunity to manufacturers, distributors, and administrators of COVID-19 vaccines and other countermeasures, except in cases of willful misconduct. The extension aims to prepare for and mitigate the credible risk presented by potential future outbreaks of COVID-19, despite the official end of the public health emergency in May 2023. Critics argue that this move benefits pharmaceutical companies by shielding them from legal accountability for vaccine-related injuries, while the administration insists it is necessary for public health preparedness.
View original story
Similar markets
Potential future pandemics • 25%
Vaccine manufacturer lobbying • 25%
Public health safety concerns • 25%
Other • 25%
Manufacturing issues • 25%
Supply chain disruptions • 25%
Increased demand • 25%
Regulatory changes • 25%
Vaccine development • 25%
Research oversight • 25%
International cooperation • 25%
Public health infrastructure • 25%
Significant changes • 25%
Minor adjustments • 25%
No changes • 25%
Reversal of certain protocols • 25%
Passed both Houses • 25%
Passed only in Senate • 25%
Passed only in House • 25%
Not passed • 25%
COVID-19 booster policy • 25%
Childhood vaccination schedules • 25%
Influenza vaccination guidelines • 25%
Other • 25%
Lack of bipartisan support • 25%
Lobbying by research institutions • 25%
Public opposition • 25%
Other • 25%
Yes • 50%
No • 50%
Increased oversight • 25%
Reduced oversight • 25%
No significant changes • 25%
Other changes • 25%